Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Non-Current Debt (2020 - 2025)

Agilon Health (AGL) has disclosed Non-Current Debt for 6 consecutive years, with $15.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 54.73% year-over-year to $15.8 million, compared with a TTM value of $15.8 million through Dec 2025, down 54.73%, and an annual FY2025 reading of $15.8 million, down 54.73% over the prior year.
  • Non-Current Debt was $15.8 million for Q4 2025 at Agilon Health, down from $34.9 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $99.4 million in Q1 2021 and bottomed at $15.8 million in Q4 2025.
  • Average Non-Current Debt over 5 years is $39.9 million, with a median of $37.2 million recorded in 2023.
  • The sharpest move saw Non-Current Debt crashed 57.58% in 2022, then rose 8.04% in 2024.
  • Year by year, Non-Current Debt stood at $43.4 million in 2021, then dropped by 11.33% to $38.5 million in 2022, then decreased by 16.04% to $32.3 million in 2023, then grew by 8.04% to $34.9 million in 2024, then tumbled by 54.73% to $15.8 million in 2025.
  • Business Quant data shows Non-Current Debt for AGL at $15.8 million in Q4 2025, $34.9 million in Q4 2024, and $34.9 million in Q3 2024.